logo-loader
viewFalcon Oil & Gas Ltd

Falcon Oil & Gas confirms successful placing for well campaign

“This placing will see the company being adequately funded through the next c.US$100mln of capital expenditure on the Beetaloo project," said Phillip O’Quigley.

oil and gas operations
Up to four wells are planned

Falcon Oil & Gas Ltd (LON:FOG) confirmed the results of its share placing, in an announcement after Friday’s market close.

The company, in a statement, said it had conditionally raised £7mln (US$9mln) with 50.5mln new shares being sold at a price of 14p each.

READ: Falcon launches US$10mln placing to support upcoming campaign

It noted that the injection of funds will primarily be used to fund Falcon’s share of costs for a new programme of drilling, hydraulic fracturing and testing across its shale acreage in Australia’s Northern Territory.

“Falcon is delighted with the proposed placing to conditionally raise c.US$9mln,” said Phillip O’Quigley, Falcon chief executive.

“This placing will see the company being adequately funded through the next c.US$100mln of capital expenditure on the Beetaloo project.

“Preparations continue for the re-commencement of drilling of Stage 2 in mid-2019, which will include the drilling and hydraulic fracture stimulation of two horizontal wells, and we look forward to updating the market in due course.”

Quick facts: Falcon Oil & Gas Ltd

Price: 13.25 GBX

AIM:FOG
Market: AIM
Market Cap: £130.09 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Falcon Oil & Gas Ltd named herein, including the promotion by the Company of Falcon Oil & Gas Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: SkinBio signs commercial deal with chemical giant Croda

Headlines from the Proactive UK newsroom. SkinBioTherapeutics (LON:SBTX) has signed a commercial and manufacturing agreement for its Skinbiotix technology with speciality chemical giant Croda.  It is the first major deal for the product with Croda to design and manufacture a new active...

1 day, 12 hours ago

2 min read